Borden Ladner Gervais LLP is pleased to provide you with the fourth annual edition of its report, Life Sciences Legal Trends in Canada (Life Signs). The report features key insights from the Life Sciences team at BLG, as well as messages from Canada's leading national and regional life sciences associations.
BLG's Life Signs report covers notable trends in the areas of Intellectual Property, Regulatory Affairs, Privacy and Cybersecurity, as well as Capital Markets, and includes articles on topics such as diagnostic inventions, CETA implications, pharmaceutical trademark protection, cannabis oil, cyber risk management and sandbagging in M&A.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
